Skip to main content

Table 2 Summary description of clinical features of patients by etiology of sARF

From: Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study

Clinical feature

Total (n = 240)

Prerenal (n = 36)

Renal (n = 203)

p value

Median age (IQR; years)

66 (53–74)

60 (48–71)

67 (54–75)

0.08

Male sex (%)

139 (58)

17 (47)

122 (60)

NS

Mean Charlson co-morbidity index (±SD)

6.2 (3.6)

6.7 (3.9)

6.1 (3.6)

NS

Mean APACHE II score (±SD)

33 (8.6)

33 (7.0)

33 (8.9)

NS

Oliguria (%)

183 (77)

33 (92)

150 (74)

0.02

Hypotension (%)

204 (85)

27 (75)

177 (87)

0.07

Vasopressors (%)

185 (77)

25 (69)

160 (79)

NS

Shock (%)

178 (74)

23 (64)

155 (76)

NS

Sepsis syndrome (%)

167 (70)

23 (64)

144 (71)

NS

Bloodstream infection (%)

50 (21)

5 (14)

45 (22)

NS

Mean arterial pH (±SD)a

7.26 (0.14)

7.18 (0.15)

7.27 (0.13)

<0.001

Mean serum potassium (±SD) (mmol/l)a

4.8 (1.1)

4.9 (1.3)

4.7 (1.1)

NS

Median serum creatinine (IQR; μmol/l)a

405 (265–515)

357 (247–514)

413 (269–517)

NS

Median serum urea (IQR; mmol/l)a

24 (16–33)

24 (16–33)

25 (16–33)

NS

Mechanical ventilation (%)

174 (73)

19 (53)

155 (76)

<0.01

Acute respiratory distress syndrome (%)

91 (41)

14 (39)

85 (42)

NS

Cardiac arrest (%)

43 (18)

6 (17)

37 (18)

NS

  1. aLaboratory values determined prior to initiation of RRT. APACHE, Acute Physiology and Chronic Health Evaluation; IQR, interquartile range; sARF, severe acute renal failure; SD, standard deviation; NS, non-significant.